goodbrain007, I was interested in the date(s) of CRLs for inhaled dihydroerotamine (Levadex), and my searches pulled up dates in 2013. Is that year approximately when the quote you cited was part of a CRL press release by Allergan?
mnholdem, I was able to find it on proboards, which I do not use much, but I appreciate your reply with details.
afact_hft_is_price_fixing, I realize you have to type fast due to time pressures, but what details about the labor union and/or the health insurance company can you provide?
I did not say I am getting paid 29.75%. That is the borrow rate. I have no idea what the rate is to those in the Fully Paid program. I decided not to participate so as not to help the shorts.
I looked just now. I even called FIDO and asked the guy what the borrow rate is right now. He said he still sees 29.75%. I asked him about 19.25%, and he said he did not see that for MNKD. Yes, I trade with FIDO. Do you?
prcgorman2, I can tell you it is almost always advisable to sell time rather than buy time in the options market. The statistic I keep in front of my mind (from long ago) with options is that about 80% of options held to expiration expire worthless. Given that, it should not take much thought to realize it is almost always better to sell the options than to buy them. Pick some conservative stock, buy it, sell some covered calls against it. Watch what happens to your learning. Alternatively pick some stock you want to own, and sell some puts at a lower strike price than it currently trades. You might get the stock put to you (you may be forced to buy it), or the put may expire worthless and you collect the premium you sold. That could amount to 10 to 12% interest per year, better than that if your timing is good when you execute the naked put. If you have never traded options, I don't think MNKD is the way to start. At the current prices of MNKD the price is like an in-the-money call anyway, and you will own the stock with a 100% delta.
I normally don't buy calls (buy time), but I was poking around and saw Jan 2017 $3 calls were trading at $2.48 while July 17 2015 calls were likely tradable at maybe $2.20 or $2.25. Looked like almost no time premium for 1.5 years of time. I already own a ton of MNKD shares, and I don't need to bother with calls. However I thought I would have some fun for a while, and I bought just 10 Jan 2017 calls for $2.50 each. They traded at 1:30 pm and 1:45 pm. I have no idea what institution, etc., sells these very long term, pretty deep in the money calls for almost no time premium even relative to like calls that expire in just one week, but thanks.
promannkind, thinking that a T2's staying on metformin is a good idea makes no sense when an ultra fast acting insulin, Afrezza, is available. Unless the T2 is too far gone, Afrezza is the way to go. If too far gone on the blood glucose, then a basal insulin plus Afrezza should be what the doctor prescribes. Metformin is a liver/kidney damager plus a pancreas squeezer. Metformin makes T1s out of T2s much of the time. It's attraction appears to be its super cheap prescription price.